Autoantibodies specific to a peptide of β2-glycoprotein I cross-react with TLR4, inducing a proinflammatory phenotype in endothelial cells and monocytes

Blood

Volumn 120, Issue 16, 2012, Pages 3360-3370

  Colasanti, Tania ^a,b   Alessandri, Cristiano ^c   Capozzi, Antonella ^c   Sorice, Maurizio ^c   Delunardo, Federica ^a   Longo, Agostina ^c   Pierdominici, Marina ^a   Conti, Fabrizio ^c   Truglia, Simona ^c   Siracusano, Alessandra ^a   Valesini, Guido ^c   Ortona, Elena ^a,b   Margutti, Paola ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84868108264     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-09-378851     Document Type: Article

References (51)

1. Hughes GR, Harris NN, Gharavi AE. The anticardiolipin syndrome. J Rheumatol. 1986;13(3):486-489.
2. Devreese K, Hoylaerts MF. Challenges in the diagnosis of the antiphospholipid syndrome. Clin Chem. 2010;56(6):930-940.
3. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295-306.
4. Galli M, Barbui T. Prothrombin as cofactor for antiphospholipids. Lupus. 1998;7(S2):S37-S40. (Pubitemid 28484578)
5. de Groot PG, Horbach DA, Derksen RH. Protein C and other cofactors involved in the binding of antiphospholipid antibodies: relation to the pathogenesis of thrombosis. Lupus. 1996;5(5):488-493. (Pubitemid 26354073)
6. Sorice M, Arcieri P, Griggi T, et al. Inhibition of protein S by autoantibodies in patients with acquired protein S deficiency. Thromb Haemost. 1996;75(4):555-559. (Pubitemid 26138259)
7. Bas de Laat H, Derksen RH, de Groot PG. beta2-Glycoprotein I, the playmaker of the antiphospholipid syndrome. Clin Immunol. 2004;112(2):161-168.
8. Bozic B, Cucnik S, Kveder T, Rozman B. Avidity of anti-beta-2- glycoprotein I antibodies. Autoimmun Rev. 2005;4(5):303-308. (Pubitemid 40884549)
9. Guerin J, Sim R, Yu BB, Ferluga J, Feighery C, Jackson J. Heterogeneous recognition of beta 2-glycoprotein I by antibodies from antiphospholipid syndrome patients. Thromb Haemost. 2000;84(3):374-380.
10. Tincani A, Balestrieri G, Spatola L, Cinquini M, Meroni PL, Roubey RA. Anticardiolipin and antibeta 2 glycoprotein immunoassays in the diagnosis of antiphospholipid syndrome. Clin Exp Rheumatol. 1998;16(4):396-402. (Pubitemid 28370849)
11. Giannakopoulos B, Passam F, Rahgozar S, Krilis SA. Current concepts on the pathogenesis of the antiphospholipid syndrome. Blood. 2007;109(2):422-430. (Pubitemid 46105935)
12. Pierangeli SS, Chen PP, Raschi E, et al. Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms. Semin Thromb Hemost. 2008;34(3):236-250.
13. Jankowski M, Vreys I, Wittevrongel C, et al. Thrombogenicity of beta2-glycoprotein I-dependent antiphospholipid antibodies in a photochemically induced thrombosis model in the hamster. Blood. 2003;101(1):157-162. (Pubitemid 36025902)
14. Meroni PL, Ronda N, De Angelis V, Grossi C, Raschi E, Borghi MO. Role of anti-beta2 glycoprotein I antibodies in antiphospholipid syndrome: in vitro and in vivo studies. Clin Rev Allergy Immunol. 2007;32(1):67-74.
15. Zhou H, Wang H, Li N, et al. Annexin A2 mediates anti-beta2GPI/beta2GPI- induced tissue factor expression on monocytes. Int J Mol Med. 2009;24(4):557-562.
16. Alard JE, Gaillard F, Daridon C, Shoenfeld Y, Jamin C, Youinou P. TLR2 is one of the endothelial receptors for beta2-glycoprotein I. J Immunol. 2010;185(3):1550-1557.
17. Satta N, Kruithof EK, Fickentscher C, et al. Tolllike receptor 2 mediates the activation of human monocytes and endothelial cells by antiphospholipid antibodies. Blood. 2011;117(20):5523-5531.
18. Meroni PL, Raschi E, Testoni C, Parisio A, Borghi MO. Innate immunity in the antiphospholipid syndrome: role of toll-like receptors in endothelial cell activation by antiphospholipid antibodies. Autoimmun Rev. 2004;3(7-8):510-515. (Pubitemid 39531243)
19. Zhou H, Yan Y, Xu G, et al. Toll-like receptor (TLR)-4 mediates anti-beta2GPI/beta2GPIinduced tissue factor expression in THP-1 cells. Clin Exp Immunol. 2011;163(2):189-198.
20. Döring Y, Hurst J, Lorenz M, et al. Human antiphospholipid antibodies induce TNFalpha in monocytes via Toll-like receptor 8. Immunobiology. 2010;215(3):230-241.
21. Meroni PL, Raschi E, Testoni C, Borghi MO. Endothelial cell activation by antiphospholipid antibodies. Clin Immunol. 2004;112(2):169-174. (Pubitemid 38881482)
22. Sorice M, Longo A, Capozzi A, et al. Anti-beta2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor alpha and tissue factor by signal transduction pathways involving lipid rafts. Arthritis Rheum. 2007;56(8):2687-2697. (Pubitemid 47237287)
23. Shi T, Giannakopoulos B, Yan X, et al. Anti-beta2-glycoprotein I antibodies in complex with beta2-glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib-IX-V. Arthritis Rheum. 2006;54(8):2558-2567. (Pubitemid 44205017)
24. Di Simone N, Raschi E, Testoni C, et al. Pathogenic role of anti-beta2-glycoprotein I antibodies in antiphospholipid associated fetal loss: characterisation of beta2-glycoprotein I binding to trophoblast cells and functional effects of anti-beta2-glycoprotein I antibodies in vitro. Ann Rheum Dis. 2005;64(3):462-467. (Pubitemid 40283060)
25. Pierangeli SS, Vega-Ostertag ME, Raschi E, et al. Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies. Ann Rheum Dis. 2007;66(10):1327-1333. (Pubitemid 47492476)
26. de Laat B, Pengo V, Pabinger I, et al. The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study. J Thromb Haemost. 2009;7(11):1767-1773.
27. de Laat B, Mertens K, de Groot PG. Mechanisms of disease: antiphospholipid antibodies-from clinical association to pathologic mechanism. Nat Clin Pract Rheumatol. 2008;4(4):192-199.
28. Ioannou Y, Rahman A. Domain I of beta2-glycoprotein I: its role as an epitope and the potential to be developed as a specific target for the treatment of the antiphospholipid syndrome. Lupus. 2010;19(4):400-405.
29. Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum. 1999;42(7):1309-1311. (Pubitemid 30265586)
30. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.
31. Wiebe CB, Putnins EE. The periodontal disease classification system of the American Academy of Periodontology-an update. J Can Dent Assoc. 2000;66(11):594-597.
32. Margutti P, Matarrese P, Conti F, et al. Autoantibodies to the C-terminal subunit of RLIP76 induce oxidative stress and endothelial cell apoptosis in immune-mediated vascular diseases and atherosclerosis. Blood. 2008;111(9):4559-4570.
33. Franca M, Moura-Costa L, Meyer RJ, Trindade SC, Tunes Uda R, Freire SM. Humoral immune response to antigens of Porphyromonas gingivalis ATCC 33277 in chronic periodontitis. J Appl Oral Sci. 2007;15(3):213-219.
34. McNeil HP, Krillis SA, Chesterman CN. Purification of anti-phospholipid antibodies using a new affinity method. Thromb Res. 1988;52:641-648. (Pubitemid 19028235)
35. Zanoni G, Navone R, Lunardi C, et al. In celiac disease, a subset of autoantibodies against transglutaminase binds toll-like receptor 4 and induces activation of monocytes. PLoS Med. 2006;3(9):e358.
36. Young IT. Proof without prejudice: use of the Kolmogorov-Smirnov test for the analysis of histograms from flow systems and other sources. J Histochem Cytochem. 1977;25(7):935-941. (Pubitemid 8170725)
37. Blank M, Krause I, Fridkin M, et al. Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome. J Clin Invest. 2002;109(6):797-804. (Pubitemid 34263156)
38. Wang D, Nagasawa T, Chen Y, et al. Molecular mimicry of Aggregatibacter actinomycetemcomitans with beta2 glycoprotein I. Oral Microbiol Immunol. 2008;23(5):401-405.
39. Vlachoyiannopoulos PG, Mavragani CP, Bourazopoulou E, Balitsari AV, Routsias JG. Anti-CD40 antibodies in antiphospholipid syndrome and systemic lupus erythematosus. Thromb Haemost. 2004;92(6):1303-1311. (Pubitemid 39642541)
40. Reyes-Moreno C, Girouard J, Lapointe R, Darveau A, Mourad W. CD40/CD40 homodimers are required for CD40-induced phosphatidylinositol 3-kinase-dependent expression of B7.2 by human B lymphocytes. J Biol Chem. 2004;279(9):7799-7806. (Pubitemid 38294664)
41. Ferro D, Pignatelli P, Loffredo L, Conti F, Valesini G, et al. Soluble CD154 plasma levels in patients with systemic lupus erythematosus: modulation by antiphospholipid antibodies. Arthritis Rheum. 2004;50(5):1693-1694. (Pubitemid 38608094)
42. Jara LJ, Medina G, Vera-Lastra O, Amigo MC. Accelerated atherosclerosis, immune response and autoimmune rheumatic diseases. Autoimmun Rev. 2006;5(3):195-201. (Pubitemid 43234184)
43. Girouard J, Reyes-Moreno C, Darveau A, Akoum A, Mourad W. Requirement of the extracellular cysteine at position six for CD40/CD40 dimer formation and CD40-induced IL-8 expression. Mol Immunol. 2005;42(7):773-780. (Pubitemid 40489026)
44. Zhu J, Mohan C. Toll-like receptor signaling pathways-therapeutic opportunities. Mediators Inflamm. 2010;2010:781235.
45. Alvarez-Rodriguez L, Muñoz Cacho P, Lopez-Hoyos M, et al. Toll-like receptor 4 gene polymorphism and giant cell arteritis susceptibility: a cumulative meta-analysis. Autoimmun Rev. 2011;10(12):790-792.
46. Allen KL, Fonseca FV, Betapudi V, Willard B, Zhang J, McCrae KR. A novel pathway for human endothelial cell activation by antiphospholipid anti-beta2 glycoprotein I antibodies. Blood. 2012;119(3):884-893.
47. He KL, Sui G, Xiong H, et al. Feedback regulation of endothelial cell surface plasmin generation by PKC-dependent phosphorylation of annexin A2. J Biol Chem. 2011;286(17):15428-15439.
48. Romay-Penabad Z, Montiel-Manzano MG, Shilagard T, et al. Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo. Blood. 2009;114(14):3074-3083.
49. Hurst J, Lorenz M, Prinz N, von Landenberg P. The roll of Toll-like receptors in the antiphospholipid syndrome. Curr Rheumatol Rep. 2010;12(1):58-63.
50. Aringer M, Smolen JS. Tumour necrosis factor and other proinflammatory cytokines in systemic lupus erythematosus: a rationale for therapeutic intervention. Lupus. 2004;13(5):344-347. (Pubitemid 38788494)
51. Liu B, Yang Y, Dai J, et al. TLR4 up-regulation at protein or gene level is pathogenic for lupus-like autoimmune disease. J Immunol. 2006;177(10):6880- 6888. (Pubitemid 44715053)